Loading clinical trials...
Loading clinical trials...
In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2
Conditions
Interventions
Patient sampling
Locations
1
Belgium
UZ Leuven
Leuven, Belgium
Start Date
March 27, 2020
Primary Completion Date
March 30, 2026
Completion Date
March 30, 2026
Last Updated
November 17, 2025
NCT06631287
NCT04262921
NCT05655351
NCT06999018
NCT05800158
NCT05726084
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions